Discharge Time And Satisfaction Score Of Patients Undergoing Endoscopies Under Intravenous Remifentanil Sedation

Discharge Time And Satisfaction Score Of Patients Undergoing Endoscopies Under Intravenous Remifentanil Sedation - A Prospective Observational Study - Nil

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/069439

Enrollment

Registered

2024-06-25

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 8- Other Procedures

Interventions

Intervention1: Intravenous Remifentanil: Patients undergoing diagnostic endoscopies will be given intravenous Remifentanil as 0.25 to 1 microgram/kg/ minute infusion along with it midazolam 1 mg bolu

Eligibility

Inclusion criteria

Inclusion criteria: Age 18 to 75 years Both males and females ASA 1 and 2

Exclusion criteria

Exclusion criteria: Age less than 18 and more than 75 years ASA 3 and above Allergic to any opioids

Design outcomes

Primary

Measure	Time frame
1. To determine the time to discharge in patients undergoing endoscopies under remifentanil sedation. 2. To assess the patient satisfaction to remifentanil sedation using Visual Analogue Scale (VAS) after the procedure.Timepoint: 1.Immediately after endoscopy 2.10 minutes after procedure	—

Secondary

Measure	Time frame
1.To evaluate sedation during endoscopies using Ramsay sedation score. 2. To determine the total and supplemental dose of Remifentanil, required for sedation. 3. To assess the surgeon’s satisfaction using a four point scale. 4. To assess the change in hemodynamic variables during and after the procedure from baseline. 5. To compare the sedation score and time to recovery with the existing data of fentanyl.Timepoint: During and After the endoscopic procedure	—

Measure

Time frame

1.To evaluate sedation during endoscopies using Ramsay sedation score. 2. To determine the total and supplemental dose of Remifentanil, required for sedation. 3. To assess the surgeon’s satisfaction using a four point scale. 4. To assess the change in hemodynamic variables during and after the procedure from baseline. 5. To compare the sedation score and time to recovery with the existing data of fentanyl.Timepoint: During and After the endoscopic procedure

—

Countries

India

Contacts

Public ContactDr Rajasree O

Regional Cancer Centre , Trivandrum

muhammedrashid93@gmail.com8156978832

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026